D. E. Shaw & Co., Inc. Gt Biopharma, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.6 - $3.3 $110,242 - $139,923	-42,401 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.05 - $7.08 $254,577 - $590,953	-83,468 Reduced 66.31%	42,401 $129,000
Q3 2021 Nov 15, 2021	BUY	$6.68 - $15.26 $722,288 - $1.65 Million	108,127 Added 609.44%	125,869 $848,000
Q2 2021 Aug 16, 2021	BUY	$7.19 - $18.96 $127,564 - $336,388	17,742 New	17,742 $275,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $77.8M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.